Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    15337732 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180)
Condition: Acute Coronary Syndrome
Interventions: Drug: A-Phase: tirofiban; Z-Phase simvastatin;   Drug: Duration of Treatment: A-Phase: minimum suggested 48 hours, maximum suggested 108 hours. Z-Phase: 2 years;   Drug: Comparator: A-Phase: low molecular weight heparin, unfractionated heparin;   Drug: Duration of Treatment: A-Phase: low molecular weight heparin, 2 to 8 days; unfractionated heparin, minium suggested 48 hours, maximum 108 hours;   Drug: Duration of Treatment: Z-Phase, 2 years.

Study has passed its completion date and status has not been verified in more than two years.